Peptidyl-prolyl isomerase-B is involved in Mycobacterium tuberculosis biofilm formation and a generic target for drug repurposing-based intervention

Probing the interaction of zero valent iron nanoparticles with blood system by biophysical, docking, cellular, and molecular studies

(2018) Babak Abbaszadeh Asl et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

Functional analysis of the cyclophilin PpiB role in bacterial cell division

(2017) Aggeliki Skagia et al.   GENES TO CELLS

Biofilms: Survival and defense strategy for pathogens

(2017) Ashutosh Kumar et al.   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

Exploring the interaction between iron oxide nanoparticles (IONPs) and Human serum albumin (HSA): Spectroscopic and docking studies

(2017) Gajalakshmi Sekar et al.   JOURNAL OF MOLECULAR LIQUIDS

Mycobacterium tuberculosis Peptidyl-Prolyl Isomerases Are Immunogenic, Alter Cytokine Profile and Aid in Intracellular Survival

(2017) Saurabh Pandey et al.   Frontiers in Cellular and Infection Microbiology

Gallium nanoparticles facilitate phagosome maturation and inhibit growth of virulent Mycobacterium tuberculosis in macrophages

(2017) Seoung-ryoung Choi et al.   PLoS One

The calcineruin inhibitor cyclosporine a synergistically enhances the susceptibility of Candida albicans biofilms to fluconazole by multiple mechanisms

(2016) Wei Jia et al.   BMC MICROBIOLOGY

Cyclophilin PpiB is involved in motility and biofilm formation via its functional association with certain proteins

(2016) Aggeliki Skagia et al.   GENES TO CELLS

Mycobacterium tuberculosis Peptidyl-Prolyl Isomerases Also Exhibit Chaperone like Activity In-Vitro and In-Vivo

(2016) Saurabh Pandey et al.   PLoS One

Siderophores in Iron Metabolism: From Mechanism to Therapy Potential

(2016) Briana R. Wilson et al.   TRENDS IN MOLECULAR MEDICINE

Chronic pulmonary disease withMycobacterium abscessuscomplex is a biofilm infection

(2015) Tavs Qvist et al.   EUROPEAN RESPIRATORY JOURNAL

Computational identification of novel piperidine derivatives as potential HDM2 inhibitors designed by fragment-based QSAR, molecular docking and molecular dynamics simulations

(2015) Aditi Singh et al.   STRUCTURAL CHEMISTRY

Genotypic and Phenotypic Profiles of Escherichia coli Isolates Belonging to Clinical Sequence Type 131 (ST131), Clinical Non-ST131, and Fecal Non-ST131 Lineages from India

(2014) Arif Hussain et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Repurposing of gallium-based drugs for antibacterial therapy

(2014) Carlo Bonchi et al.   BIOFACTORS

The calcineurin inhibitor cyclosporin A exhibits synergism with antifungals against Candida parapsilosis species complex

(2014) R. d. A. Cordeiro et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Microbial Peptidyl-Prolyl cis/trans Isomerases (PPIases): Virulence Factors and Potential Alternative Drug Targets

(2014) C. M. Unal et al.   MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS

The dimeric nature of bonding in gallium: from small clusters to the α-gallium phase

(2014) Ralf Tonner et al.   PHYSICAL CHEMISTRY CHEMICAL PHYSICS

Metformin as adjunct antituberculosis therapy

(2014) A. Singhal et al.   Science Translational Medicine

Inhibition of cyclophilin D by cyclosporin A promotes retinal ganglion cell survival by preventing mitochondrial alteration in ischemic injury

(2014) S Y Kim et al.   Cell Death & Disease

Challenges and opportunities of drug repositioning

(2013) Natalia Novac   TRENDS IN PHARMACOLOGICAL SCIENCES

New Life for an Old Drug: the Anthelmintic Drug Niclosamide Inhibits Pseudomonas aeruginosa Quorum Sensing

(2012) F. Imperi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Intracellularly Induced Cyclophilins Play an Important Role in Stress Adaptation and Virulence of Brucella abortus

(2012) Mara S. Roset et al.   INFECTION AND IMMUNITY

Successful Shortening of Tuberculosis Treatment Using Adjuvant Host-Directed Therapy with FDA-Approved Phosphodiesterase Inhibitors in the Mouse Model

(2012) Mamoudou Maiga et al.   PLoS One

Cyclophilin Inhibitors: An Emerging Class of Therapeutics for the Treatment of Chronic Hepatitis C Infection

(2012) Sam Hopkins et al.   Viruses-Basel

Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A

(2012) Ravikumar B Shinde et al.   Annals of Clinical Microbiology and Antimicrobials

Redox homeostasis in mycobacteria: the key to tuberculosis control?

(2011) Ashwani Kumar et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

Microtiter Dish Biofilm Formation Assay

(2011) George A. O'Toole   Jove-Journal of Visualized Experiments

Pseudomonas aeruginosabiofilms in cystic fibrosis

(2010) Niels Høiby et al.   Future Microbiology

Defining Hormesis: Evaluation of a Complex Concentration Response Phenomenon

(2010) Eric L. Kendig et al.   INTERNATIONAL JOURNAL OF TOXICOLOGY

Structural and Biochemical Characterization of the Human Cyclophilin Family of Peptidyl-Prolyl Isomerases

(2010) Tara L. Davis et al.   PLOS BIOLOGY

Synergistic Effect of Calcineurin Inhibitors and Fluconazole against Candida albicans Biofilms

(2008) P. Uppuluri et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The mycobacterial glycopeptidolipids: structure, function, and their role in pathogenesis

(2008) J. S Schorey et al.   GLYCOBIOLOGY

Growth ofMycobacterium tuberculosisbiofilms containing free mycolic acids and harbouring drug-tolerant bacteria

(2008) Anil K. Ojha et al.   MOLECULAR MICROBIOLOGY